Premium

Alternative Insight and Premium Journalism

Latest Articles

(Mark Kauzlarich/Bloomberg)

ValueAct Unveils Newest Target

Stephen Taub September 13, 2019

Anthony Todd, CEO of Aspect Capital (David Paul Morris/Bloomberg)

CTAs Surge, but Assets Slump

Stephen Taub September 12, 2019

(Michael Nagle/Bloomberg)

These Hedge Funds Rose in a Volatile Month

Michelle Celarier September 12, 2019

David Shaw (Kimberly White/Bloomberg)

The Little-Known Fund Driving D.E. Shaw’s Gains This Year

Stephen Taub September 11, 2019

Illustration by II

Caxton Associates Gets a Boost From ESG

Stephen Taub September 10, 2019

Mark Trudeau, CEO of Mallinckrodt (Chris Goodney/Bloomberg)

Short Sellers Won in Mallinckrodt Mess, but Some Hedgies Held On

Michelle Celarier September 10, 2019

(Krisztian Bocsi/Bloomberg)

Hedge Funds Ramped Up Private Investments This Summer

Stephen Taub September 9, 2019

Ray Dalio (Patrick T. Fallon/Bloomberg)

Bridgewater’s Main Strategy Sinks in August

Stephen Taub September 6, 2019

(Daniel Acker/Bloomberg)

Are Crowded Hedge Fund Stocks Signaling Trouble Ahead?

Michelle Celarier September 5, 2019

(Qilai Shen/Bloomberg)

Tiger Global Extends Gains

Stephen Taub September 5, 2019

Bill Ackman (Patrick T. Fallon/Bloomberg)

Bill Ackman’s Publicly Traded Hedge Fund Hits Its High-Water Mark

Michelle Celarier September 4, 2019

Dan Loeb (David Paul Morris/Bloomberg)

Equities Giveth, but Credit Taketh Away for Third Point

Stephen Taub September 4, 2019

(Gabby Jones/Bloomberg)

Hedge Fund Favorite JUUL Rakes in Big Bucks in Latest Fund Raise

Stephen Taub September 4, 2019

David Einhorn (Alex Flynn/Bloomberg)

Greenlight’s Funds Fall Sharply in August

Stephen Taub September 3, 2019

Barry Rosenstein (Andrew Harrer/Bloomberg)

Jana Launches Activist Campaign Against Bloomin’ Brands — Again

Stephen Taub September 3, 2019

Ken Griffin at the Delivering Alpha conference. (Heidi Gutman/CNBC)

Citadel’s Quiet Drug Fix

Steve Taub August 30, 2019

Johannes Berg/Bloomberg

Tiger Global Poised to Benefit From Peloton IPO

Steve Taub August 29, 2019

Oleg Nodelman (Amanda Gordon/Bloomberg)

EcoR1 Targets Biotech Company

Stephen Taub August 28, 2019

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2026 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.18.01 build:2026-04-01 Login